NCT06314230

Australian Genomics Of Chronic Allograft Dysfunction Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Western Sydney Local Health District · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The goal of the Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a single centre (Westmead Hospital), prospective, observational study, which enrols patients at time of kidney (or kidney-transplant) transplant and tracks the post transplant course. The AUSCAD study aims to generate new knowledge and improve outcomes following kidney transplantation. The primary aim is to determine whether important outcomes (including chronic rejection and graft loss) are correlated with patterns of allograft reactivity, gene expression and susceptibility profiles.

Conditions

• Kidney Transplant Rejection
• Kidney Transplant; Complications

Timeline

• Start date: 2012-04-26
• Primary completion: 2040-01-01
• Completion: 2040-01-01
• First posted: 2024-03-15
• Last updated: 2025-07-17

Locations

2 sites across 1 country: Australia